Literature DB >> 22844360

The importance of molecular cytogenetic analysis prior to using cell lines in research: The case of the KG-1a leukemia cell line.

Franca Pelliccia1, Valentina Ubertini, Nazario Bosco.   

Abstract

KG-1 and its less differentiated subline KG-1a are leukemia cell lines used in research in a number of laboratories. The karyotypes of the two lines were initially identical. In the following years, further analysis revealed that the cell lines had acquired additional karyotypical abnormalities and differed in the presence of certain typical chromosomal rearrangements. To obtain cytogenetic authentication prior to the use of the two cell lines, we analyzed their karyotype by combining DAPI- and CMA-chromosome bandings and a fluorescence in situ hybridization (FISH)-based approach by using BAC clones useful for the identification of chromosome regions of interest. Sequences of the MYC, PLZF, RARA and BCR genes, that are known to play a critical role in leukemogenesis, and certain BAC clones mapped to five known common fragile sites (CFS) were used for the FISH analysis. A telomeric probe (TTAGGG)n and a set of BAC clones were used to characterize the marker chromosome der(1) that was observed in the cell line KG-1a. The existence of notable differences between the karyotype of the KG-1a cell line previously described, and that described in this study, demonstrate that the use of established cancer cell lines should be preceded by cytogenetic and/or molecular characterization.

Entities:  

Year:  2012        PMID: 22844360      PMCID: PMC3402744          DOI: 10.3892/ol.2012.709

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  10 in total

Review 1.  Common fragile sites.

Authors:  M F Arlt; A M Casper; T W Glover
Journal:  Cytogenet Genome Res       Date:  2003       Impact factor: 1.636

2.  Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.

Authors:  Krzysztof Mrózek; Stephan M Tanner; Kristiina Heinonen; Clara D Bloomfield
Journal:  Genes Chromosomes Cancer       Date:  2003-11       Impact factor: 5.006

Review 3.  The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?

Authors:  Peyton Hughes; Damian Marshall; Yvonne Reid; Helen Parkes; Cohava Gelber
Journal:  Biotechniques       Date:  2007-11       Impact factor: 1.993

4.  Improved telomere detection using a telomere repeat probe (TTAGGG)n generated by PCR.

Authors:  J W Ijdo; R A Wells; A Baldini; S T Reeders
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

5.  Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines.

Authors:  A J Furley; B R Reeves; S Mizutani; L J Altass; S M Watt; M C Jacob; P van den Elsen; C Terhorst; M F Greaves
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

6.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

7.  Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562 - Molecular characterization of FRA2H and localization of a new CFS FRA2S.

Authors:  Franca Pelliccia; Nazario Bosco; Angela Rocchi
Journal:  Cancer Lett       Date:  2010-09-18       Impact factor: 8.679

8.  Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.

Authors:  Letetia Jones; Guangwei Wei; Sabina Sevcikova; Vernon Phan; Sachi Jain; Angell Shieh; Jasmine C Y Wong; Min Li; Joshua Dubansky; Mei Lin Maunakea; Rachel Ochoa; George Zhu; Thelma R Tennant; Kevin M Shannon; Scott W Lowe; Michelle M Le Beau; Scott C Kogan
Journal:  J Exp Med       Date:  2010-11-08       Impact factor: 14.307

9.  RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.

Authors:  Fabien Guidez; Sarah Parks; Henna Wong; Jelena V Jovanovic; Ashley Mays; Amanda F Gilkes; Kenneth I Mills; Marie-Claude Guillemin; Robin M Hobbs; Pier Paolo Pandolfi; Hugues de Thé; Ellen Solomon; David Grimwade
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

10.  An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1).

Authors:  H P Koeffler; R Billing; A J Lusis; R Sparkes; D W Golde
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.